Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
A randomized controlled study to compare the efficacy of mirabegron, solifenacin and
propevirine for treatment of Lower urinary tract symptoms during intravesical BCG
installation